Results 191 to 200 of about 2,132,628 (263)

Disease Course After Anti‐CD20 Discontinuation in Secondary Progressive Multiple Sclerosis—A Multicenter Long‐Term Longitudinal Study

open access: yesAnnals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective To describe long‐term outcomes after anti‐CD20 discontinuation in selected patients with secondary progressive multiple sclerosis (SPMS) who remained without subsequent disease‐modifying therapy (DMT). Methods We retrospectively analyzed data from four centers in Austria and Switzerland.
Ferdinand Otto   +12 more
wiley   +1 more source

Histopathological Evidence of Neurodegenerative Pathology in Epilepsy: A Systematic Review

open access: yesAnnals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Epilepsy affects > 50 million people worldwide and is associated with a disproportionate burden of cognitive impairment. Emerging evidence suggests that neurodegenerative proteinopathies, particularly hyperphosphorylated tau (p‐tau) and amyloid‐β (Aβ), may contribute to cognitive dysfunction in people with epilepsy (PWE), even in the absence ...
Syeda Amrah Hashmi   +7 more
wiley   +1 more source

Antibacterial Effects of Nanobubble Water and Its Potential Application in Healthcare-associated Infection Control. [PDF]

open access: yesIn Vivo
Yoshida T   +10 more
europepmc   +1 more source

Micro- and Nano-Bots for Infection Control. [PDF]

open access: yesAdv Mater
Rashidy Ahmady A   +5 more
europepmc   +1 more source

Organizational readiness for implementing infection control in European hospitals: insights from Coincidence Analysis. [PDF]

open access: yesImplement Sci Commun
Caci L   +5 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy